Top Blue Chip Stocks To Own Right Now

Shutterstock

Don’t take any stated yields for granted these days! The financial news has been flooded with dividend cuts lately, with Teva Pharmaceutical (TEVA) and Mattel (MAT) taking the hatchet to their payouts, and telecom Windstream (WIN) dropping its dividend too.

It’s dangerous to buy headline yields – or even supposedly “safe” blue chips with more modest dividends – without looking at the profits funding these payouts. Companies with high payout ratios (how much in earnings, funds from operations and other measures a company pays out in the form of dividends) are a twofold risk:

High payout ratios can lead to a slowing in dividend growth, which means your payout is increasingly likely to fall behind inflation.

Top Blue Chip Stocks To Own Right Now: First BanCorp.(FBP)

Advisors’ Opinion:

  • [By Logan Wallace]

    Prudential Financial Inc. lessened its position in First BanCorp (NYSE:FBP) by 16.5% in the first quarter, Holdings Channel reports. The institutional investor owned 906,869 shares of the bank’s stock after selling 179,820 shares during the period. Prudential Financial Inc.’s holdings in First BanCorp were worth $5,459,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    Shares of First Bancorp (NYSE:FBP) have earned an average rating of “Buy” from the eight brokerages that are presently covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy rating. The average twelve-month price objective among brokerages that have covered the stock in the last year is $9.63.

  • [By Ethan Ryder]

    First Bancorp (NYSE:FBP) was upgraded by equities researchers at ValuEngine from a “hold” rating to a “buy” rating in a report issued on Friday.

Top Blue Chip Stocks To Own Right Now: Midland States Bancorp, Inc. (MSBI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    News headlines about Midland States Bancorp (NASDAQ:MSBI) have been trending somewhat positive on Saturday, Accern Sentiment reports. The research group rates the sentiment of press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Midland States Bancorp earned a daily sentiment score of 0.16 on Accern’s scale. Accern also gave news coverage about the financial services provider an impact score of 44.8228508822808 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Logan Wallace]

    Midland States Bancorp Inc (NASDAQ:MSBI) Director John M. Schultz sold 2,000 shares of the stock in a transaction that occurred on Monday, September 17th. The shares were sold at an average price of $33.70, for a total transaction of $67,400.00. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Midland States Bancorp (MSBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Blue Chip Stocks To Own Right Now: Controladora Vuela Compania de Aviacion, S.A.B. de C.V.(VLRS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Prothena Corporation plc (NASDAQ: PRTA) shares dipped 69 percent to $11.48 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction.
    Gridsum Holding Inc. (NASDAQ: GSUM) fell 44.3 percent to $4.06. Gridsum reported suspension of audit report on financial statements.
    Flotek Industries, Inc. (NYSE: FTK) shares declined 34.1 percent to $4.16 as the company issued weak revenue forecast for the first quarter.
    Akorn, Inc. (NASDAQ: AKRX) dropped 32.3 percent to $13.35 after Fresenius terminated its merger deal with Akorn.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 31.2 percent to $13.44. Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron.
    Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS) dropped 18 percent to $5.76. Controladora Vuela recently reported first-quarter results that showed a loss for the quarter. Imperial Capital downgraded Controladora Vuela Compania de Aviacion from Outperform to In-Line.
    Atossa Genetics Inc. (NASDAQ: ATOS) fell 18.2 percent to $2.8797 after declining 19.35 percent on Friday.
    Alcoa Corporation (NYSE: AA) fell 12.3 percent to $52.63.
    Luby's, Inc. (NYSE: LUB) shares declined 10.3 percent to $2.448 following Q2 results.
    Aceto Corporation (NASDAQ: ACET) shares tumbled 10 percent to $2.26.
    Pier 1 Imports, Inc. (NYSE: PIR) dipped 9.7 percent

  • [By Adam Levine-Weinberg]

    In late 2016 and early 2017, profitability deteriorated rapidly at Mexican budget airline Volaris (NYSE:VLRS) due to market disruptions caused by the U.S. presidential election. Fears about a crackdown on trade or immigration under President Trump led to a sharp drop in the Mexican peso and a downturn in travel demand. However, Volaris seemed to be on the mend by this time last year, and its stock price rebounded to more than $15 last July.

  • [By Max Byerly]

    Volaris (NYSE:VLRS)’s share price hit a new 52-week high and low during trading on Wednesday . The stock traded as low as $5.07 and last traded at $5.22, with a volume of 64285 shares trading hands. The stock had previously closed at $5.19.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Controladora Vuela Co Avcn SA CV (VLRS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Travis Hoium]

    Shares of Mexican airline Controladora Vuela Co Avcn SA CV (NYSE:VLRS) plunged as much as 20.3% in trading Monday after announcing earnings that led to fears of growing competition. At 12:25 p.m. EDT shares were still down 16.6% on the day. 

Top Blue Chip Stocks To Own Right Now: Virtu Financial, Inc.(VIRT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Virtu Financial (NASDAQ: VIRT) and Nomura (NYSE:NMR) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, dividends and analyst recommendations.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Extreme Networks, Inc. (NASDAQ: EXTR) fell 26 percent to $8.70 in pre-market trading after the company reported downbeat earnings for its third quarter and issued weak Q4 guidance.
    Caesarstone Ltd. (NASDAQ: CSTE) shares fell 12.5 percent to $16.15 in pre-market trading after the company reported downbeat Q1 results and lowered its FY18 sales forecast.
    MINDBODY, Inc. (NASDAQ: MB) fell 11.7 percent to $38.65 in pre-market trading following mixed Q1 results.
    Vivint Solar, Inc. (NYSE: VSLR) fell 10 percent to $3.60 in pre-market trading after reporting Q1 miss.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) shares fell 10 percent to $31.63 in pre-market trading after reporting a Q1 earnings miss at 28 cents per share, 5 cents below estimates.
    Monster Beverage Corporation (NASDAQ: MNST) fell 7.7 percent to $49.00 in pre-market trading after reporting downbeat quarterly earnings.
    MaxLinear, Inc. (NYSE: MXL) fell 6.1 percent to $22.39 in pre-market trading following Q1 earnings.
    Virtu Financial, Inc. (NASDAQ: VIRT) fell 5.3 percent to $31.1604 in pre-market trading after announcing a 15 million share common stock secondary offering.
    Papa John's International, Inc. (NASDAQ: PZZA) shares fell 4.7 percent to $56 in pre-market trading after reporting downbeat Q1 earnings

  • [By Lisa Levin] Companies Reporting Before The Bell
    Celgene Corporation (NASDAQ: CELG) is projected to report quarterly earnings at $1.96 per share on revenue of $3.46 billion.
    Aon plc (NYSE: AON) is expected to report quarterly earnings at $2.8 per share on revenue of $2.93 billion.
    American Axle & Manufacturing Holdings, Inc. (NYSE: AXL) is estimated to report quarterly earnings at $0.81 per share on revenue of $1.75 billion.
    Alibaba Group Holding Limited (NYSE: BABA) is expected to report quarterly earnings at $0.88 per share on revenue of $9.27 billion.
    LifePoint Health, Inc. (NASDAQ: LPNT) is projected to report quarterly earnings at $1.13 per share on revenue of $1.62 billion.
    V.F. Corporation (NYSE: VFC) is estimated to report quarterly earnings at $0.65 per share on revenue of $2.90 billion.
    Newell Brands Inc. (NYSE: NWL) is expected to report quarterly earnings at $0.26 per share on revenue of $3.05 billion.
    Titan International, Inc. (NYSE: TWI) is projected to report quarterly earnings at $0.04 per share on revenue of $407.27 million.
    Boise Cascade Company (NYSE: BCC) is expected to report quarterly earnings at $0.45 per share on revenue of $1.09 billion.
    Cheniere Energy, Inc. (NYSE: LNG) is estimated to report quarterly earnings at $0.39 per share on revenue of $1.59 billion.
    Cboe Global Markets, Inc. (NASDAQ: CBOE) is projected to report quarterly earnings at $1.24 per share on revenue of $308.05 million.
    ITT Inc. (NYSE: ITT) is estimated to report quarterly earnings at $0.73 per share on revenue of $683.96 million.
    Fred's, Inc. (NASDAQ: FRED) is expected to report quarterly loss at $0.19 per share on revenue of $551.00 million.
    Virtu Financial, Inc. (NASDAQ: VIRT) is projected to report quarterly earnings at $0.52 per share on revenue of $288.31 million.
    Cheniere Energy Partners, L.P. (NYSE: CQP) is expected to report quarterly earnings at $0.57 per share on revenue of $1.38 billion.
    Genesis Energy, L.P

Top Blue Chip Stocks To Own Right Now: Patriot National, Inc.(PN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Media stories about Patriot National (NYSE:PN) have trended somewhat negative on Thursday, Accern reports. The research group identifies positive and negative news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Patriot National earned a media sentiment score of -0.01 on Accern’s scale. Accern also gave news articles about the financial services provider an impact score of 42.7409526634833 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Top Blue Chip Stocks To Own Right Now: Viking Therapeutics, Inc.(VKTX)

Advisors’ Opinion:

  • [By George Budwell]

    Shares of the clinical-stage biotech Viking Therapeutics (NASDAQ:VKTX) gained a whopping 27% last month, according to data from S&P Global Market Intelligence. What sparked this breakout?

  • [By George Budwell]

    Viking Therapeutics (NASDAQ:VKTX), a clinical-stage biotech, has seen its shares rise by more than 900% in the past 12 months. However, the biotech’s shares have taken a breather in the past few sessions, thanks to President Donald Trump’s ongoing trade war that has rocked the broader markets. 

  • [By George Budwell]

    Amarin Corporation (NASDAQ:AMRN) and Viking Therapeutics (NASDAQ:VKTX), for example, are two biotech stocks that offer considerably more upside potential than Tilray does right now. Read on to find out more.   

  • [By George Budwell]

    Over the past year, for example, gene therapy company uniQure N.V. (NASDAQ:QURE) and endocrine specialist Viking Therapeutics (NASDAQ:VKTX) both saw their shares skyrocket against the backdrop of a fairly weak overall market for biotech. Despite their rapid appreciation, though, these two stocks might still be incredible bargains for investors comfortable with high levels of risk. Here’s why.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Viking Therapeutics (VKTX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Sean Williams, Keith Speights, and Todd Campbell]

    So we asked three Motley Fool contributors to name a small-cap stock in which they see a lot of potential right now. They think that at the top of your buy list should be drug stocks Viking Therapeutics (NASDAQ:VKTX) and Acceleron Pharma (NASDAQ:XLRN), along with mining company SSR Mining (NASDAQ:SSRM). 

Leave a Reply

Your email address will not be published. Required fields are marked *